Checkpoint Therapeutics
CKPT
CKPT was delisted on the 29th of May, 2025.
67 hedge funds and large institutions have $22.8M invested in Checkpoint Therapeutics in 2022 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 19 increasing their positions, 16 reducing their positions, and 9 closing their positions.
78% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 9
29% more call options, than puts
Call options by funds: $489K | Put options by funds: $379K
19% more repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 16
8% more funds holding
Funds holding: 62 → 67 (+5)
0.28% more ownership
Funds ownership: 1.4% → 1.68% (+0.28%)
32% less capital invested
Capital invested by funds: $33.4M → $22.8M (-$10.6M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
+$2.38M |
| 2 |
Renaissance Technologies
New York
|
+$1.5M |
| 3 |
Two Sigma Investments
New York
|
+$810K |
| 4 |
Millennium Management
New York
|
+$700K |
| 5 |
Group One Trading
Chicago,
Illinois
|
+$377K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.48M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$475K |
| 3 |
KC
Kepos Capital
New York
|
-$311K |
| 4 |
D.E. Shaw & Co
New York
|
-$219K |
| 5 |
JSMC
Jess S. Morgan & Co
Los Angeles,
California
|
-$174K |
CKPT Hedge Fund Activity: Q1 2022 in Review
67 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Checkpoint Therapeutics (CKPT) for Q1 2022, worth a combined $22.8M — down 32% from $33.4M a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new CKPT positions and 9 closed out — a net gain of 7 holders — while 19 added to existing stakes and 16 trimmed.
The largest buyer was Healthcare of Ontario Pension Plan (HOOPP) Trust Fund, opening a new position worth an estimated $2.38M. The largest seller was Susquehanna International Group, cutting an estimated $1.48M.
- 67 institutional investors held Checkpoint Therapeutics (CKPT) as of Q1 2022, up from 62 in Q4 2021.
- Funds reported $22.8M of Checkpoint Therapeutics stock for Q1 2022, down 32% quarter-over-quarter.
- 16 funds opened new Checkpoint Therapeutics positions in Q1 2022 and 9 closed out, a net change of +7 holders.
- The largest Checkpoint Therapeutics buyer in Q1 2022 was Healthcare of Ontario Pension Plan (HOOPP) Trust Fund, an estimated $2.38M added.
- The largest Checkpoint Therapeutics seller in Q1 2022 was Susquehanna International Group, an estimated $1.48M sold.
Based on aggregated 13F filings for Q1 2022.